{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:57:45Z","timestamp":1791161865540,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00702-012-0887-7","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T02:02:00Z","timestamp":1345082520000},"page":"487-496","source":"Crossref","is-referenced-by-count":98,"title":["Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy"],"prefix":"10.1007","volume":"120","author":[{"given":"Wolfgang H.","family":"Jost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hefter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,17]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","volume":"64","author":"R Benecke","year":"2005","unstructured":"Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949\u20131951","journal-title":"Neurology"},{"issue":"8","key":"887_CR2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.53.8.640","volume":"53","author":"JD Blackie","year":"1990","unstructured":"Blackie JD, Lees AJ (1990) Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 53(8):640\u2013643","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"887_CR3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.46.4.1066","volume":"46","author":"JW Brans","year":"1996","unstructured":"Brans JW, Lindeboom R, Snoek JW, Zwarts MJ, van Weerden TW, Brunt ER, van Hilten JJ, van der Kamp W, Prins MH, Speelman JD (1996) Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 46(4):1066\u20131072","journal-title":"Neurology"},{"issue":"7","key":"887_CR4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","volume":"53","author":"A Brashear","year":"1999","unstructured":"Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53(7):1439\u20131446","journal-title":"Neurology"},{"issue":"7","key":"887_CR5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","volume":"53","author":"MF Brin","year":"1999","unstructured":"Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O\u2019Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53(7):1431\u20131438","journal-title":"Neurology"},{"issue":"1","key":"887_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","volume":"35","author":"RE Burke","year":"1985","unstructured":"Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35(1):73\u201377","journal-title":"Neurology"},{"issue":"9","key":"887_CR7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/01.WNL.0000142962.11881.26","volume":"63","author":"SJ Cano","year":"2004","unstructured":"Cano SJ, Warner TT, Linacre JM, Bhatia KP, Thompson AJ, Fitzpatrick R, Hobart JC (2004a) Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 63(9):1629\u20131633","journal-title":"Neurology"},{"issue":"9","key":"887_CR8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mds.20055","volume":"19","author":"SJ Cano","year":"2004","unstructured":"Cano SJ, Hobart JC, Fitzpatrick R, Bhatia K, Thompson AJ, Warner TT (2004b) Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord 19(9):1054\u20131059","journal-title":"Mov Disord"},{"issue":"12","key":"887_CR9","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/01.wnl.0000249310.25427.f2","volume":"67","author":"SJ Cano","year":"2006","unstructured":"Cano SJ, Hobart JC, Edwards M, Fitzpatrick R, Bhatia K, Thompson AJ, Warner TT (2006) CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology 67(12):2230\u20132232","journal-title":"Neurology"},{"key":"887_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","volume":"6","author":"J Chan","year":"1991","unstructured":"Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia\u2014clinical characteristics. Mov Disord 6:119\u2013126","journal-title":"Mov Disord"},{"issue":"4","key":"887_CR11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.42.4.878","volume":"42","author":"CL Comella","year":"1992","unstructured":"Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG (1992) Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 42(4):878\u2013882","journal-title":"Neurology"},{"issue":"4","key":"887_CR12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.870120414","volume":"12","author":"CL Comella","year":"1997","unstructured":"Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE (1997) Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12(4):570\u2013575","journal-title":"Mov Disord"},{"issue":"3","key":"887_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10377","volume":"18","author":"CL Comella","year":"2003","unstructured":"Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, Dystonia Study Group (2003) Rating scales for dystonia: a multicenter assessment. Mov Disord 18(3):303\u2013312","journal-title":"Mov Disord"},{"key":"887_CR14","first-page":"211","volume-title":"Therapy with botulinum toxin","author":"ES Consky","year":"1994","unstructured":"Consky ES, Lang AE (1994) Clinical assessments of patients with cervical dystonia. In: Jancovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York, pp 211\u2013237"},{"issue":"suppl 1","key":"887_CR15","first-page":"445","volume":"40","author":"ES Consky","year":"1990","unstructured":"Consky ES, Basinki A, Belle L, Ranawaya R, Lang AE (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40(suppl 1):445","journal-title":"Neurology"},{"issue":"1","key":"887_CR16","first-page":"CD003633","volume":"25","author":"J Costa","year":"2005","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005a) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 25(1):CD003633","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"887_CR17","first-page":"CD004314","volume":"25","author":"J Costa","year":"2005","unstructured":"Costa J, Borges A, Esp\u00edrito-Santo C, Ferreira J, Coelho M, Moore P, Sampaio C (2005b) Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 25(1):CD004314","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"887_CR18","first-page":"CD004315","volume":"25","author":"J Costa","year":"2005","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005c) Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 25(1):CD004315","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"887_CR19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00002826-199106000-00011","volume":"14","author":"RM Dubinsky","year":"1991","unstructured":"Dubinsky RM, Gray CS, Vetere-Overfield B, Koller WC (1991) Electromyographic guidance of botulinum toxin treatment in cervical dystonia. Clin Neuropharmacol 14(3):262\u2013267","journal-title":"Clin Neuropharmacol"},{"key":"887_CR20","first-page":"241","volume-title":"Quantification of neurologic deficit","author":"S Fahn","year":"1989","unstructured":"Fahn S (1989) Assessment of primary dystonias. In: Munsat TL (ed) Quantification of neurologic deficit. Butterworths, London, pp 241\u2013270"},{"issue":"1","key":"887_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.39.1.80","volume":"39","author":"DJ Gelb","year":"1989","unstructured":"Gelb DJ, Lowenstein DH, Aminoff MJ (1989) Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 39(1):80\u201384","journal-title":"Neurology"},{"issue":"8","key":"887_CR22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","volume":"40","author":"P Greene","year":"1990","unstructured":"Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E (1990) Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 40(8):1213\u20131218","journal-title":"Neurology"},{"key":"887_CR23","unstructured":"Jankovic J, Tolosa E (2007) Parkinsons\u2019s disease and movement disorders, 5th edn. Lippincott Williams & Wilkins, Philadelphia"},{"issue":"6","key":"887_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4155\/cli.11.63","volume":"1","author":"C Kamm","year":"2011","unstructured":"Kamm C, Benecke R (2011) Botulinum toxin therapy for cervical dystonia: review of the clinical evidence and ongoing studies. Clin Invest 1(6):891\u2013900","journal-title":"Clin Invest"},{"issue":"3","key":"887_CR25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","volume":"49","author":"MF Lew","year":"1997","unstructured":"Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD (1997) Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49(3):701\u2013707","journal-title":"Neurology"},{"issue":"4","key":"887_CR26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/mds.870130417","volume":"13","author":"R Lindeboom","year":"1998","unstructured":"Lindeboom R, Brans JW, Aramideh M, Speelman HD, De Haan RJ (1998) Treatment of cervical dystonia: a comparison of measures for outcome assessment. Mov Disord 13(4):706\u2013712","journal-title":"Mov Disord"},{"issue":"9","key":"887_CR27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.54.9.813","volume":"54","author":"AP Moore","year":"1991","unstructured":"Moore AP, Blumhardt LD (1991) A double blind trial of botulinum toxin \u201cA\u201d in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 54(9):813\u2013816","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"887_CR28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.2003.013441","volume":"75","author":"J M\u00fcller","year":"2004","unstructured":"M\u00fcller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A, Wenning GK, Poewe W (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75(5):749\u2013753","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"887_CR29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/mds.1226","volume":"16","author":"C O\u2019Brien","year":"2001","unstructured":"O\u2019Brien C, Brashear A, Cullis P, Truong D, Molho E, Jenkins S, Wojcieszek J, O\u2019Neil T, Factor S, Seeberger L (2001) Cervical dystonia severity scale reliability study. Mov Disord 16(6):1086\u20131090","journal-title":"Mov Disord"},{"issue":"4","key":"887_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/165019771994264191195","volume":"26","author":"T Odergren","year":"1994","unstructured":"Odergren T, Tollb\u00e4ck A, Borg J (1994) Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation. Scand J Rehabil Med 26(4):191\u2013195","journal-title":"Scand J Rehabil Med"},{"issue":"4","key":"887_CR31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","volume":"23","author":"EJ Pappert","year":"2008","unstructured":"Pappert EJ, Germanson T, Myobloc\/Neurobloc European Cervical Dystonia Study Group (2008) Botulinum toxin type B vs. type A in toxin-na\u00efve patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord 23(4):510\u2013517","journal-title":"Mov Disord"},{"issue":"1","key":"887_CR32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","volume":"64","author":"W Poewe","year":"1998","unstructured":"Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, Kessler KR, Ceballos-Baumann AO, Ohly A, Oertel W, K\u00fcnig G, German Dystonia Study Group (1998) What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. J Neurol Neurosurg Psychiatry 64(1):13\u201317","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"887_CR33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.baga.2011.01.001","volume":"1","author":"G Reichel","year":"2011","unstructured":"Reichel G (2011) Cervical dystonia: a new phenomenological classification for botulinum toxin therapy. Basal Ganglia 1:5\u201312","journal-title":"Basal Ganglia"},{"issue":"3","key":"887_CR34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1015291021312","volume":"11","author":"Scientific Advisory Group of the Medical Outcomes Trust","year":"2002","unstructured":"Scientific Advisory Group of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11(3):193\u2013205","journal-title":"Qual Life Res"},{"key":"887_CR35","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallet M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y (2008) Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699\u20131706","journal-title":"Neurology"},{"issue":"2","key":"887_CR36","first-page":"95","volume":"22","author":"J Slawek","year":"2007","unstructured":"Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G (2007) Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol 22(2):95\u2013100","journal-title":"Funct Neurol"},{"issue":"Suppl 1","key":"887_CR37","first-page":"117","volume":"24","author":"S Sommer","year":"2009","unstructured":"Sommer S, Viga R, Petersen H, Koletzki E, Jost W (2009) Zerviton: a new tool to measure head position in patients with cervical dystonia: preliminary results. Mov Disord 24(Suppl 1):117\u2013118","journal-title":"Mov Disord"},{"issue":"7","key":"887_CR38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/jnnp.51.7.920","volume":"51","author":"R Stell","year":"1988","unstructured":"Stell R, Thompson PD, Marsden CD (1988) Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry 51(7):920\u2013923","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"887_CR39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","volume":"12","author":"D Tarsy","year":"1997","unstructured":"Tarsy D (1997) Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 12(1):100\u2013102","journal-title":"Mov Disord"},{"issue":"6","key":"887_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.parkreldis.2006.06.002","volume":"12","author":"DD Truong","year":"2006","unstructured":"Truong DD, Jost WH (2006) Botulinum toxin: clinical use. Parkinsonism Relat Disord 12(6):331\u2013355","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"887_CR41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","volume":"20","author":"D Truong","year":"2005","unstructured":"Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL (2005) Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20(7):783\u2013791","journal-title":"Mov Disord"},{"issue":"4","key":"887_CR42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","volume":"12","author":"JK Tsui","year":"1985","unstructured":"Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Calne DB (1985) A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 12(4):314\u2013316","journal-title":"Can J Neurol Sci"},{"issue":"8501","key":"887_CR43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","volume":"2","author":"JK Tsui","year":"1986","unstructured":"Tsui JK, Eisen A, Stoessl AJ, Calne S, Calne DB (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2(8501):245\u2013247","journal-title":"Lancet"},{"issue":"3 Suppl","key":"887_CR44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S0317167100038063","volume":"14","author":"JK Tsui","year":"1987","unstructured":"Tsui JK, Fross RD, Calne S, Calne DB (1987) Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sci 14(3 Suppl):533\u2013555","journal-title":"Can J Neurol Sci"},{"key":"887_CR45","volume-title":"Movement disorders: a comprehensive survey","author":"WJ Weiner","year":"1989","unstructured":"Weiner WJ, Lang AE (1989) Movement disorders: a comprehensive survey. Futura, Mount Kisco, NY"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0887-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T05:57:19Z","timestamp":1687672639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0887-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,17]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0887-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,17]]}}}